A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Rajavtihi Neuronal Adult Stem Cells Project
- Status
- WITHDRAWN
- Phase
- PHASE2
Cataract Removal and Alzheimer's Disease
- Status
- COMPLETED
- Phase
- NA
Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
- Status
- COMPLETED
- Phase
- N/A
Effect of LY2062430 on the Progression of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Effect of LY2062430 on the Progression of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Evolution of Memory Related Activity
- Status
- UNKNOWN
- Phase
- N/A
Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Implications of Amyloid Pathology
- Status
- UNKNOWN
- Phase
- N/A
Citalopram for Agitation in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Non-Interventional Study With Aricept® Evess
- Status
- COMPLETED
- Phase
- N/A